CATT Study Update 9: The CATT Study is On Track
According to an official with the CATT Study, it is on track and proceeding well. The 44 participating centers have recruited over 850 of the called-for 1200 enrollments and anticipate completing patient enrollment by the end of the year.
One-year results from the study are expected to be released in early 2011.
The study began enrolling patients in February 2008.
For more on this historic study, please see my prior Updates listed below:
CATT Study Update (June 2007)
The first hint that there might be a study.
CATT Study Update 2: Avastin vs. Lucentis – It’s Official! (September 2007)
Confirmation that the study will get underway.
CATT Study Update 3: Avastin vs. Lucentis – To Get Underway by Year’s End! (September 2007)
Additional information from the September meeting of potential clinical participants. Patient enrollment was supposed to begin by end of 2007 – it was delayed by announcements from Genentech
CATT Study Update 4: Avastin vs. Lucentis Study Ready to Roll (November 2007)
.UPenn gets its official website up and running.
CATT Study Update 5: First Official Listing of Clinical Trial Sites (January 2008)
NIH gets its website up and running.
CATT Study Update 6: Official Announcement of Trial Start from NEI (February 2008)
NEI releases press release announcing official start of the program.
CATT Study Update 7: An Interesting Commentary by Dr. James Folk (September 2008)
Interesting commentary by Dr. James Folk on the CATT Study.
CATT Study Update 8: The Story Behind The CATT Study (October 2008)
The story behind the story of how the CATT Study really happened – by the people who made it happen.